Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
HAMILTON, Bermuda, June 04, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024 at 8:40 a.m. Eastern Time.
百慕大哈密爾頓，2024年6月4日（全球新聞社）— kiniksa pharmaceuticals有限公司。（納斯達克：KNSA）今天宣佈，公司管理層將參加高盛45的觀摩會議。thKiniksa的演講將在公司網站的投資者和媒體版塊上通過直播網絡傳輸。大會回顧也將在演講後約48小時內在Kiniksa的網站上提供。
A live webcast of Kiniksa's presentation will be accessible through the Investors & Media section of the company's website at www.kiniksa.com. A replay of the event will also be available on Kiniksa's website within approximately 48 hours after the event.
Kiniksa的演示現場網絡直播可通過公司網站的投資者和媒體板塊 &（www.kiniksa.com）訪問。www.kiniksa.com是再生元製藥公司的註冊商標。該活動的重播也將在活動結束後約48小時內在Kiniksa的網站上提供。
About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa's immune-modulating assets, ARCALYST, abiprubart, and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.
ARCALYST是再生元製藥公司的註冊商標。
Kiniksa是一家商業化階段的生物製藥公司，專注於發現、收購、開發和商業化治療那些患有嚴重未滿足醫療需求的疾病患者的治療藥物。Kiniksa的免疫調節資產，ARCALYST阿比普魯巴特（abiprubart）和馬伕利姆單抗（mavrilimumab）基於強有力的生物學原理或經過驗證的機制，針對一系列未得到滿足的心血管和自身免疫疾病，並提供差異化潛力。欲了解更多信息，請訪問（www.kiniksa.com）。www.kiniksa.com是再生元製藥公司的註冊商標。.
ARCALYST is a registered trademark of Regeneron Pharmaceuticals, Inc.
ARCALYST再生元製藥公司的註冊商標。
Every Second Counts!
Kiniksa Investor and Media Contact
Rachel Frank
(339) 970-9437
rfrank@kiniksa.com
每一秒都尤爲重要！
Kiniksa投資者和媒體聯繫人
Rachel Frank
(339) 970-9437
rfrank@kiniksa.com
譯文內容由第三人軟體翻譯。